These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 2887588)

  • 1. Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.
    Maier W; Albus M; Buller R; Nutzinger D; Shera D; Bech P
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):103-8. PubMed ID: 2149648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of bedtime dosing of benzodiazepines: a placebo-controlled comparison of halazepam and clorazepate.
    Aden GC; O'Hair DE
    Clin Ther; 1980; 3(3):209-18. PubMed ID: 6109568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of rating form for evaluating anxiolytics.
    Wang RI; Kochar C
    Psychopharmacol Bull; 1989; 25(2):291-5. PubMed ID: 2574898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R; Annable L; Chouinard G; Ogilvie RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):80-7. PubMed ID: 6132936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
    Stokes DK
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of self-report assessment in studies of anxiety disorders.
    Glass RM; Uhlenhuth EH; Kellner R
    J Clin Psychopharmacol; 1987 Aug; 7(4):215-21. PubMed ID: 2887588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the use of behavioral rating scales in studies evaluating the efficacy of antianxiety and antidepressant drugs.
    Fankhauser MP; German ML
    Am J Hosp Pharm; 1987 Sep; 44(9):2087-100. PubMed ID: 2890299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical methodology for testing of anxiolytic drugs.
    Bourin M
    Therapie; 2000; 55(1):147-53. PubMed ID: 10860018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antianxiety agents in anxious outpatients.
    Rickels K
    Psychopharmacology (Berl); 1978 Jun; 58(1):1-17. PubMed ID: 27835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should DSM-III-R GAD criteria be used for studies of anxiolytics?
    Mattes JA; Konig PH
    Biol Psychiatry; 1993 Feb; 33(4):302-3. PubMed ID: 8097116
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.